ArticleClinical kidney journal2020

Glucagon-like peptide-1 receptor and sarcoglycan delta genetic variants can affect cardiovascular risk in chronic kidney disease patients under hemodialysis.

Annalisa Terranegra et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.